Onkolojik Hastalarda Koroner Arter Bypass Greft (KABG) Uygulanımı

Navi BB, Reiner AS, Kamel H ve ark. Risk of artheriel thromboembolism in patients with cancer. Journal of the American Collage of Cardiology 2017; 70(8):926-938

Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J. 2020 Aug 29;ehaa575. doi: 10.1093

Al-Hawwas M, Tsitlakidou D, Gupta N ve ark. Acute coronary syndrome management in cancer patients.Current Oncology Reports 2018; 20(10):78

Neumann FJ, Sousa-Uva M, Ahlsson A ve ark. 2018 ESC / EACTS guidelines on myocardial revascularisation. European Heart Journal 2019; 40(2):87-165

Crawford ES, Morris GC Jr, Howel JF ve ark. Operative risks in patients with previous coronary artery bypass. Ann Thorac Surg 1978; 26:215-21

Giza DA, Boccalandro F, Lopez-Mattei J ve ark. Ischemic heart disease: special considerations in cardio-oncology. Curr Treat Options Cardio Med 2017; 19:1-13

Yeh ETH, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C et al Cardiovascular complications of cancer therapy. Circulation 2004;109: 3122–31

Carrascal Y, Gualis J, Arévalo A, Fulquet E, Flórez S, Rey J, et al. Cirugía cardiaca con circulación extracorpórea en pacientes oncológicos: influencia en la morbimortalidad quirúrgica y la supervivencia. Rev Esp Cardiol. 2008;61:369-75

Chan J, Rosenfeldt F, Chaudhuri K, Marasco S. Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. Heart Lung Circ 2012;21:255-9

Hirose H, Amano A, Yoshida S ve ark. Coronary artery bypass grafting in patients with malignant neoplasm. The Journal of Thoracic and Cardiovascular Surgery 2000; 48:96-100

Nardi P, Pellegrino A, Pugliese M, Bovio E, Chiariello L, Ruvolo G. Cardiac surgery with extracorporeal circulation and concomitant malignancy: early and long-term results. J Cardiovasc Med 2016;17:152–9

Vieira RD, Pereira AC, Lima EG, Garzillo CL, Rezende PC, Favarato D et al. Cancer-related deaths among different treatment options in chronic coronary artery disease: results of a 6-year follow-up of the MASS II study. Coron Artery Dis 2012;23:79–84

Schoenmakers MCJ, van Boven W-J, van den Bosch J, van Swieten HA. Comparison of on-pump or off-pump coronary artery revascularization with lung resection. Ann Thorac Surg 2007;84:504–9

Suzuki S, Usui A, Yoshida K, Matsuura A, Ichihara T, Ueda Y. Effect of cardiopulmonary bypass on cancer prognosis. Asian Cardiovasc Thorac Ann 2010;18:536–40

Potapov EV, Zurbru¨gg HR, Herzke C, Srock S, Riess H, Sodian R et al. Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study. Ann Thorac Surg 2002;74:384–9